Dundee Biotech PhaSER Wins $2.7M Gates Grant for Infectious Disease Drugs
The renewal expands access to PhaSER’s humanised mouse model and supports work on TB, malaria and other neglected diseases.
3 Articles
3 Articles
Dundee biotech PhaSER wins $2.7M Gates grant for infectious disease drugs
Scottish biotech PhaSER Biomedical has won a $2.7M (£2m) grant from the Gates Foundation to help find new drugs for diseases such as TB and malaria. The company announced the award in a statement this morning. The two-year grant renews PhaSER’s place in the foundation’s Global Health Discovery Collaboratory, a programme that gives Gates-funded teams access […] This story continues at The Next Web
PHASER Receives $2.7 Million From the Gates Foundation to Look for Drugs Against Infectious Diseases
Scottish biotechnology company PHASER Biomedical obtained a two-year grant for $2.7 million from the Gates Foundation to promote research on drugs against infectious diseases. Support renews its participation in a global program that allows scientists to access its 8HUM mouse model, designed to process drugs more similar to patients.
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
